-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Responsible Editor: Food Science
As one of the important chassis cells of synthetic biology, Saccharomyces cerevisiae can be used to develop traditional brewed foods, bulk chemicals and high value-added products
Recently, the evolution and metabolic engineering research team led by Wang Qinhong, a researcher at the Tianjin Institute of Industrial Biotechnology , Chinese Academy of Sciences , based on the design and modification of the endogenous double-strand break (DNA double-strand break, DSB) repair pathway of Saccharomyces cerevisiae and CRISPR genome editing, established A highly efficient template-independent mutagenic genome editing (mGE) technology has been developed, and the heritable diversity of targeted genes can be regulated in expression .
The related research results were published in Microbiology Spectrum
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.